FDA advisers recommend easing Avandia restrictions

Measures that imposed limits on patients while accessing the diabetes pill Avandia have been eased by an advisory panel of the US Food and Drug Administration. However, according to a number of panelists, precautions were still required. As per ...

Health experts have said restrictions on GlaxoSmithKline's once blockbuster diabetes drug Avandia should be eased after they found heart risks may have been overstated. The British pharmaceutical giant is currently fighting compensation claims from ...

The restrictions on prescribing and taking GlaxoSmithKline's controversial diabetes drug Avandia may be eased or removed after advisers to the US Food and Drug Administration found that the risk of cardiovascular events may be overstated. 13 out ...

WASHINGTON, June 5 ( ) - A U.S. Food and Drug Administration panel of outside experts reopened one of the biggest drug controversies in recent years on Wednesday at a meeting where they will decide whether to recommend lifting marketing restrictions ...

The controversial diabetes drug Avandia should stay on the market for now, with relaxed restrictions on its use, Food and Drug Administration advisers said on Thursday. The FDA has been reconsidering its approval of Avandia, which was the worlds ...

Good news recently flowed in at GlaxoSmithKline (GSK) when the joint advisory committee (comprising Endocrinologic and Metabolic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee) to the US Food and Drug ...

An advisory panel to the Food and Drug Administration on Thursday voted to keep the diabetes drug Avandia on the market with a slate of restrictions on its use, and suggested that although evidence of the drug's safety problems may have been ...

Advisers plan to take a break to assess problem with vote tally and plan to re-vote on GSK's Avandia after break,